Getting the picture – faster

The challenge To effectively diagnose, treat and monitor patients, clinicians require easy access to a variety of images and reports – both new and historic. Image sharing at present however can be a slow and frustrating process, suffering from the inherent delays of a manual process: image retrieval can take up to four hours. Following the regional implementation of the 100,000 Genomes Project by the West Midlands Genomic Medicine Centre (WMGMC), the need for a … Continue reading “Getting the picture – faster”

Pulse oximetry: Lyla’s story

Born on 2 September 2015, Lyla Parry’s heart condition was finally detected when she was 11 days old and only when she was in heart failure. If pulse oximetry screening had been part of the routine newborn checks her condition could have been detected sooner. This is her story, as told by her mum, Janine Parry, of Northampton. I had gestational diabetes throughout my pregnancy with Lyla, my second child, so I was closely monitored because … Continue reading “Pulse oximetry: Lyla’s story”

Digitalising disease data

The challenge Across the country, thousands of genomic and complex health data sets are stored. To harness the power of these records in designing new treatments, the first task was to co-ordinate them, to allow efficient tracking and analysing of samples. The solution As a Global Digital Exemplar, BHP founder member University Hospitals Birmingham NHS Foundation Trust is renowned for its expertise in using informatics to improve patient care. And, with one of the most … Continue reading “Digitalising disease data”

Trialling personalised cancer medicine

The challenge Non-small cell lung cancer is the most common type of lung cancer. However, as it is caused by a range of specific mutations which vary between patients, individuals won’t all respond in the same way to the same treatment. This presents a clear opportunity for the use of precision medicine – however, setting up numerous individual clinical trials can be a barrier as it is inefficient in terms of patient care and investment … Continue reading “Trialling personalised cancer medicine”